Chinese biotechnology firm Rundo International has raised RMB100 million (US$14.85 million) in a series C round of financing from the country’s private equity firm Riverhead Capital, according to a statement released by the company on Monday.
Chinese Biotech Firm Rundo International Raises Nearly $15M In Series C Round comes originally from China Money Network. All Rights Reserved.